About Ultima-Ultrazompic
Ultima-Ultrazompic 2mg is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist peptide manufactured by Ultima Peptides for laboratory research applications. This peptide compound represents a class of incretin mimetics that selectively bind to GLP-1 receptors, modulating glucose-dependent insulin secretion pathways in cellular research models. Researchers at Stroid UK Shop can access this 2mg formulation for detailed metabolic pathway investigations and in-vitro studies examining GLP-1 receptor pharmacology.
Laboratory Research Applications
Scientists investigate Ultima-Ultrazompic in preclinical models studying glucose homeostasis, insulin sensitivity, and pancreatic beta-cell function. The compound enables researchers to examine GLP-1 receptor activation mechanisms, evaluate glucose-dependent insulin release patterns, and study incretin hormone signalling pathways. Laboratory investigations focus on understanding receptor binding kinetics, downstream signalling cascades, and metabolic regulatory mechanisms. Researchers in the semaglutide research category analyse this compound alongside other selective receptor modulators and peptide research tools for comprehensive metabolic studies.
Technical Specifications
| Product Name | Ultima-Ultrazompic |
|---|---|
| Peptide Content | 2mg per vial |
| Manufacturer | Ultima Peptides |
| Form | Lyophilised powder |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Requirements | -20°C, protect from light |
| Reconstitution | Bacteriostatic water recommended |
Research Compliance
Ultima-Ultrazompic 2mg is supplied exclusively for in-vitro laboratory research purposes. This peptide is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must maintain appropriate storage conditions and handle according to institutional biosafety protocols. All investigations should comply with relevant research guidelines and institutional review requirements for peptide research compounds.
